Literature DB >> 33244234

Effect of Starvation in Reversing Cancer Chemoresistance Based on Drug-Resistance Detection by Dextran Nanoparticles.

Chenglong Wang1, Xuzhu Gao1, Fanchen Wang1, Wencai Guan1, Hongjing Dou2, Guoxiong Xu1.   

Abstract

INTRODUCTION: Chemoresistance leads to chemotherapy failure in patients with cancer. Multidrug resistance (MDR) in cancer is mainly caused by the high expression of P-glycoprotein encoded by the MDR1 gene, which is an ATP-dependent protease. Keeping the stronger invasion and migration abilities of chemoresistant cells in cancer also requires more ATP consumption. Herein, we aimed to reverse resistance by reducing the glucose supply in the cellular environment.
METHODS: A starvation approach in reversing chemoresistance was applied, which was implemented through preparing fluorescent dextran-based nanoparticles to detect the proportion of chemoresistant cells in the chemoresistant/chemosensitive cell mixture after cells cultured in a low-glucose condition.
RESULTS: Chemoresistant cells had higher glucose consumption with higher ATPase expression and stronger glucose dependence compared to chemosensitive cells. Moreover, cancer cells cultured in a low-glucose condition reduced the proportion of chemoresistant cells.
CONCLUSION: Starvation therapy can be used as a new method to reverse drug resistance in cancer.
© 2020 Wang et al.

Entities:  

Keywords:  P-glycoprotein; cancer drug-resistance; nanoparticles; resistance reversal; starvation therapy

Mesh:

Substances:

Year:  2020        PMID: 33244234      PMCID: PMC7685360          DOI: 10.2147/IJN.S283430

Source DB:  PubMed          Journal:  Int J Nanomedicine        ISSN: 1176-9114


  31 in total

Review 1.  The challenge of drug resistance in cancer treatment: a current overview.

Authors:  Michail Nikolaou; Athanasia Pavlopoulou; Alexandros G Georgakilas; Efthymios Kyrodimos
Journal:  Clin Exp Metastasis       Date:  2018-05-24       Impact factor: 5.150

Review 2.  Starvation, detoxification, and multidrug resistance in cancer therapy.

Authors:  Changhan Lee; Lizzia Raffaghello; Valter D Longo
Journal:  Drug Resist Updat       Date:  2012-03-04       Impact factor: 18.500

Review 3.  Metronomic chemotherapy: A potent macerator of cancer by inducing angiogenesis suppression and antitumor immune activation.

Authors:  Eirini Biziota; Leonidas Mavroeidis; Eleftheria Hatzimichael; Periklis Pappas
Journal:  Cancer Lett       Date:  2016-12-23       Impact factor: 8.679

4.  Scalable and cleavable polysaccharide nanocarriers for the delivery of chemotherapy drugs.

Authors:  Hao Wang; Tingting Dai; Shengli Li; Shuyan Zhou; Xiaojing Yuan; Jiayi You; Chenglong Wang; Vincent Mukwaya; Guangdong Zhou; Guojun Liu; Xiaohui Wei; Hongjing Dou
Journal:  Acta Biomater       Date:  2018-03-20       Impact factor: 8.947

Review 5.  An update on overcoming MDR1-mediated multidrug resistance in cancer chemotherapy.

Authors:  Kohji Takara; Toshiyuki Sakaeda; Katsuhiko Okumura
Journal:  Curr Pharm Des       Date:  2006       Impact factor: 3.116

6.  Bio-inspired gene carriers with low cytotoxicity constructed via the assembly of dextran nanogels and nano-coacervates.

Authors:  Chenglong Wang; Jiayi You; Miaomiao Gao; Peipei Zhang; Guoxiong Xu; Hongjing Dou
Journal:  Nanomedicine (Lond)       Date:  2020-05-29       Impact factor: 5.307

Review 7.  Gene therapy for breast cancer. --Review of clinical gene therapy trials for breast cancer and MDR1 gene therapy trial in Cancer Institute Hospital.

Authors:  Shunji Takahashi; Yoshinori Ito; Kiyohiko Hatake; Yoshikazu Sugimoto
Journal:  Breast Cancer       Date:  2006       Impact factor: 4.239

Review 8.  The progress and development of GLUT1 inhibitors targeting cancer energy metabolism.

Authors:  Ying Meng; Xi Xu; Hongyu Luan; Lei Li; Wenhao Dai; Zhiyu Li; Jinlei Bian
Journal:  Future Med Chem       Date:  2019-09       Impact factor: 3.808

Review 9.  Cancer metabolism: New insights into classic characteristics.

Authors:  Yasumasa Kato; Toyonobu Maeda; Atsuko Suzuki; Yuh Baba
Journal:  Jpn Dent Sci Rev       Date:  2017-09-29

Review 10.  Tumor Endothelial Heterogeneity in Cancer Progression.

Authors:  Nako Maishi; Dorcas A Annan; Hiroshi Kikuchi; Yasuhiro Hida; Kyoko Hida
Journal:  Cancers (Basel)       Date:  2019-10-09       Impact factor: 6.639

View more
  1 in total

1.  Tamoxifen-resistant breast cancer cells exhibit reactivity with Wisteria floribunda agglutinin.

Authors:  May Thinzar Hlaing; Yoshiya Horimoto; Kaori Denda-Nagai; Haruhiko Fujihira; Miki Noji; Hiroyuki Kaji; Azusa Tomioka; Yumiko Ishizuka; Harumi Saeki; Atsushi Arakawa; Mitsue Saito; Tatsuro Irimura
Journal:  PLoS One       Date:  2022-08-25       Impact factor: 3.752

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.